This company has been marked as potentially delisted and may not be actively trading. LogicBio Therapeutics (LOGC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSustainabilityTrendsBuy This Stock LOGC vs. MYTE, BWMX, VGII, OG, WNW, OGBLY, BBW, ETD, BH, and VLGEAShould you be buying LogicBio Therapeutics stock or one of its competitors? The main competitors of LogicBio Therapeutics include MYT Netherlands Parent B.V. (MYTE), Betterware de México, S.A.P.I. de C.V. (BWMX), Virgin Group Acquisition Corp. II (VGII), Onion Global (OG), Meiwu Technology (WNW), Onion Global (OGBLY), Build-A-Bear Workshop (BBW), Ethan Allen Interiors (ETD), Biglari (BH), and Village Super Market (VLGEA). LogicBio Therapeutics vs. Its Competitors MYT Netherlands Parent B.V. Betterware de México, S.A.P.I. de C.V. Virgin Group Acquisition Corp. II Onion Global Meiwu Technology Onion Global Build-A-Bear Workshop Ethan Allen Interiors Biglari Village Super Market LogicBio Therapeutics (NASDAQ:LOGC) and MYT Netherlands Parent B.V. (NYSE:MYTE) are both small-cap retail/wholesale companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk. Is LOGC or MYTE more profitable? MYT Netherlands Parent B.V. has a net margin of -3.98% compared to LogicBio Therapeutics' net margin of -141.03%. MYT Netherlands Parent B.V.'s return on equity of -5.88% beat LogicBio Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets LogicBio Therapeutics-141.03% -81.98% -52.13% MYT Netherlands Parent B.V. -3.98%-5.88%-3.63% Do analysts prefer LOGC or MYTE? MYT Netherlands Parent B.V. has a consensus target price of $14.00, indicating a potential upside of 90.48%. Given MYT Netherlands Parent B.V.'s stronger consensus rating and higher possible upside, analysts clearly believe MYT Netherlands Parent B.V. is more favorable than LogicBio Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score LogicBio Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00MYT Netherlands Parent B.V. 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Do institutionals and insiders believe in LOGC or MYTE? 46.1% of LogicBio Therapeutics shares are held by institutional investors. Comparatively, 10.1% of MYT Netherlands Parent B.V. shares are held by institutional investors. 8.1% of LogicBio Therapeutics shares are held by company insiders. Comparatively, 1.9% of MYT Netherlands Parent B.V. shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Which has more volatility and risk, LOGC or MYTE? LogicBio Therapeutics has a beta of 2.06, indicating that its stock price is 106% more volatile than the S&P 500. Comparatively, MYT Netherlands Parent B.V. has a beta of 1.08, indicating that its stock price is 8% more volatile than the S&P 500. Does the media prefer LOGC or MYTE? In the previous week, LogicBio Therapeutics' average media sentiment score of 0.00 equaled MYT Netherlands Parent B.V.'saverage media sentiment score. Company Overall Sentiment LogicBio Therapeutics Neutral MYT Netherlands Parent B.V. Neutral Which has better earnings and valuation, LOGC or MYTE? MYT Netherlands Parent B.V. has higher revenue and earnings than LogicBio Therapeutics. MYT Netherlands Parent B.V. is trading at a lower price-to-earnings ratio than LogicBio Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioLogicBio Therapeutics$287M0.67-$317M-$5.79-1.27MYT Netherlands Parent B.V.$881.44M0.71-$26.95M-$0.43-17.09 SummaryMYT Netherlands Parent B.V. beats LogicBio Therapeutics on 10 of the 14 factors compared between the two stocks. Get LogicBio Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for LOGC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding LOGC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart LOGC vs. The Competition Export to ExcelMetricLogicBio TherapeuticsCatalog & mail IndustryRetail SectorNASDAQ ExchangeMarket Cap$193.42M$262.59M$26.34B$9.01BDividend YieldN/A12.64%175.57%4.03%P/E Ratio-1.272.2629.2120.17Price / Sales0.6712.315.36124.64Price / CashN/A58.4747.2757.86Price / Book0.822.845.765.62Net Income-$317M$4.74M$869.96M$248.50M LogicBio Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)LOGCLogicBio Therapeutics1.4281 of 5 stars$7.36-1.7%N/A+32.3%$193.42M$287M-1.2762Gap DownMYTEMYT Netherlands Parent B.V.N/A$7.90-2.3%$14.00+77.2%+63.7%$677.02M$881.44M-18.371,240BWMXBetterware de México, S.A.P.I. de C.V.3.4984 of 5 stars$8.60-1.7%N/A-29.8%$320.93M$14.00B6.141,270News CoverageVGIIVirgin Group Acquisition Corp. IIN/A$1.10-4.3%N/A-31.6%$55.34MN/A0.00N/AOGOnion GlobalN/AN/AN/AN/A$25.02M$2.04B0.00796WNWMeiwu TechnologyN/A$1.95+11.8%N/A-87.1%$6.17M$158.49K0.0050Gap UpOGBLYOnion GlobalN/AN/AN/AN/A$11KN/A0.00860BBWBuild-A-Bear Workshop2.0262 of 5 stars$51.43-5.0%$51.33-0.2%+105.2%$714.98M$496.40M12.365,100ETDEthan Allen Interiors3.7993 of 5 stars$27.85-0.3%$32.00+14.9%+9.2%$710.01M$646.22M12.383,404News CoverageBHBiglari1.2963 of 5 stars$291.92+0.2%N/A+59.6%$663.24M$362.11M-1.332,535High Trading VolumeVLGEAVillage Super Market3.2994 of 5 stars$38.50-0.2%N/A+43.6%$569.14M$2.24B10.167,300News CoveragePositive NewsHigh Trading Volume Related Companies and Tools Related Companies MYT Netherlands Parent B.V. Alternatives Betterware de México, S.A.P.I. de C.V. Alternatives Virgin Group Acquisition Corp. II Alternatives Onion Global Alternatives Meiwu Technology Alternatives Onion Global Alternatives Build-A-Bear Workshop Alternatives Ethan Allen Interiors Alternatives Biglari Alternatives Village Super Market Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:LOGC) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LogicBio Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share LogicBio Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LOGC Stock Alerts